Watson Hit With False Marking Suit Over Androderm
Watson Pharmaceuticals Inc. has been accused of listing expired patents for its Androderm testosterone deficiency treatment, as well as blocking innovation in the industry....To view the full article, register now.
Already a subscriber? Click here to view full article